In‐hospital mortality among patients with invasive non‐group A β‐hemolytic Streptococcus treated with clindamycin combination therapy: a nationwide cohort study

In‐hospital mortality among patients with invasive non‐group A β‐hemolytic Streptococcus treated with clindamycin combination therapy: a nationwide cohort study

Aim Combination treatment with clindamycin is recommended in patients with invasive group A Streptococcus infection; however, whether the same treatment is effective in invasive group B Streptococcus and S. dysgalactiae subspecies equisimilis infections remains unknown. We aimed to investigate wheth...

Full description

Bibliographic Details
Main Authors: Shoichiro Hamada, Mikio Nakajima, Richard H. Kaszynski, Ryosuke Kumazawa, Hiroki Matui, Kiyohide Fushimi, Hideaki Goto, Yoshihiro Yamaguchi, Hideo Yasunaga
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Acute Medicine & Surgery
Subjects:
β‐Hemolytic Streptococcus
clindamycin
invasive Streptococcus infection
Streptococcus agalactiae
Streptococcus dysgalactiae subspecies equisimilis
Online Access:https://doi.org/10.1002/ams2.634

Internet

https://doi.org/10.1002/ams2.634

Similar Items